Helio Miot, MD, PhD, with Bob Kronemyer The first head-to-head comparison study of cysteamine cream to hydroquinone for the treatment of recalcitrant melasma has found the relatively new topical agent to be safe, well-tolerated and effective, despite its inferior performance to hydroquinone
B12 injections have very low toxicity, but adverse reactions can occur
This unique weight loss formulation uses two top rated scientifically studied weight loss ingredients for powerful weight loss results
Bulk formats available upon approval
avoid vigorous shaking to prevent denaturing the peptide
Future studies should validate these findings in animal models and further evaluate the long-term effects of C3G therapy on glucose homeostasis and insulin sensitivity, as well as the potential side effects of long-term use of C3G